Veterinary Medicines Information website

LAPINJECT VHD

Not authorised
  • Rabbit haemorrhagic disease virus, Inactivated
Download as PDF

Product identification

Medicine name:
LAPINJECT VHD
Active substance:
  • Rabbit haemorrhagic disease virus, Inactivated
Target species:
  • Rabbit
  • Rabbit (for reproduction)
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Rabbit haemorrhagic disease virus, Inactivated
    1.00
    100% protective dose
    /
    1.00
    unit(s)
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Rabbit
      • All relevant tissues
        0
        day
    • Rabbit (for reproduction)
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI08AA01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • France
Package description:
  • Pack of 1 glass vial (2,5 ml) of 5 doses
  • Pack of 1 glass vial (100 ml) of 200 doses
  • Pack of 10 glass vials (20 ml) of 40 doses
  • Pack of 2 glass vials (20 ml) of 40 doses
  • Pack of 1 glass vial (20 ml) of 40 doses
  • Pack of 10 glass vials (10 ml) of 20 doses
  • Pack of 1 glass vial (10 ml) of 20 doses
  • Pack of 10 glass vials (5 ml) of 10 doses
  • Pack of 1 glass vial (5 ml) of 10 doses

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Ceva Sante Animale
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Hipra S.A.
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/8903726 7/2003
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0163/001

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 4/04/2022
Download